NCT04807192View on ClinicalTrials.gov

CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Triple Negative Breast Cancer
Interventions
RADIATION

stereotactic body radiotherapy

one administration of SBRT 8 Gy at D1

DRUG

CMP-001

4 sequential administrations of CMP001 at Day 1 (SC), Day 5 (±1) (IT), Day 9 (±1) (IT) and Day 16 (±1) (IT)

Trial Locations (1)

1011

CHUV Oncology Department, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER